ATE181911T1 - Neurotensin-aktive substituierte 1- naphthylpyrazol-3-carboxamide, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Neurotensin-aktive substituierte 1- naphthylpyrazol-3-carboxamide, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE181911T1 ATE181911T1 AT94402263T AT94402263T ATE181911T1 AT E181911 T1 ATE181911 T1 AT E181911T1 AT 94402263 T AT94402263 T AT 94402263T AT 94402263 T AT94402263 T AT 94402263T AT E181911 T1 ATE181911 T1 AT E181911T1
- Authority
- AT
- Austria
- Prior art keywords
- naphthylpyrazole
- carboxamides
- neurotensin
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PNLLWTUHUQZJRP-UHFFFAOYSA-N 4-naphthalen-1-yl-1h-pyrazole-5-carboxamide Chemical class N1N=CC(C=2C3=CC=CC=C3C=CC=2)=C1C(=O)N PNLLWTUHUQZJRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
- C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
- C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312136A FR2711140B1 (fr) | 1993-10-12 | 1993-10-12 | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181911T1 true ATE181911T1 (de) | 1999-07-15 |
Family
ID=9451754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94402263T ATE181911T1 (de) | 1993-10-12 | 1994-10-10 | Neurotensin-aktive substituierte 1- naphthylpyrazol-3-carboxamide, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US5502059A (de) |
| EP (1) | EP0647629B1 (de) |
| JP (1) | JPH07278114A (de) |
| KR (1) | KR950011413A (de) |
| CN (1) | CN1108651A (de) |
| AT (1) | ATE181911T1 (de) |
| AU (1) | AU685154B2 (de) |
| CA (1) | CA2117821A1 (de) |
| DE (1) | DE69419377D1 (de) |
| FI (1) | FI944770A (de) |
| FR (1) | FR2711140B1 (de) |
| HU (1) | HUT70048A (de) |
| IL (1) | IL111239A0 (de) |
| NO (1) | NO304595B1 (de) |
| NZ (1) | NZ264661A (de) |
| RU (1) | RU2140912C1 (de) |
| TW (1) | TW300890B (de) |
| ZA (1) | ZA947957B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6492411B1 (en) | 1993-11-30 | 2002-12-10 | G. D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| US6716991B1 (en) | 1993-11-30 | 2004-04-06 | G. D. Searle & Co. | Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| FR2732967B1 (fr) * | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| US6521561B1 (en) | 1998-05-01 | 2003-02-18 | President And Fellows Of Harvard College | Main-group metal based asymmetric catalysts and applications thereof |
| IL142707A0 (en) | 2000-04-27 | 2002-03-10 | Pfizer Prod Inc | Methods of treating obesity using a neurotensin receptor ligand |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| CN1237119C (zh) * | 2001-05-11 | 2006-01-18 | 三井化学株式会社 | 掺杂剂和含有其的导电聚合物材料 |
| US6603000B2 (en) | 2001-07-11 | 2003-08-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Synthesis for heteroarylamine compounds |
| PT1414800E (pt) * | 2001-07-11 | 2005-04-29 | Boehringer Ingelheim Pharma | Nova sintese de compostos de heteroarilamina |
| AR038967A1 (es) * | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina |
| GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
| GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| CA2594488C (en) * | 2005-01-10 | 2015-04-28 | University Of Connecticut | Novel heteropyrrole analogs acting on cannabinoid receptors |
| US7714014B2 (en) * | 2005-12-09 | 2010-05-11 | The Regents Of The University Of California | Targeting GLI proteins in human cancer by small molecules |
| WO2007094962A2 (en) * | 2006-02-09 | 2007-08-23 | Athersys, Inc. | Pyrazoles for the treatment of obesity and other cns disorders |
| EP2740726A1 (de) * | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin-Rezeptorligande |
| RU2705800C2 (ru) | 2014-06-06 | 2019-11-12 | Рисерч Трайэнгл Инститьют | Агонисты рецептора апелина (apj) и их применение |
| WO2017100558A1 (en) | 2015-12-09 | 2017-06-15 | Research Triangle Institute | Improved apelin receptor (apj) agonists and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| US5288877A (en) * | 1991-07-03 | 1994-02-22 | Ppg Industries, Inc. | Continuous process for preparing indolenine compounds |
| IL104311A (en) * | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1993
- 1993-10-12 FR FR9312136A patent/FR2711140B1/fr not_active Expired - Fee Related
-
1994
- 1994-10-10 AT AT94402263T patent/ATE181911T1/de not_active IP Right Cessation
- 1994-10-10 EP EP94402263A patent/EP0647629B1/de not_active Expired - Lifetime
- 1994-10-10 DE DE69419377T patent/DE69419377D1/de not_active Expired - Lifetime
- 1994-10-11 FI FI944770A patent/FI944770A/fi unknown
- 1994-10-11 CA CA002117821A patent/CA2117821A1/en not_active Abandoned
- 1994-10-11 RU RU94036749A patent/RU2140912C1/ru active
- 1994-10-11 NO NO943837A patent/NO304595B1/no unknown
- 1994-10-11 IL IL11123994A patent/IL111239A0/xx unknown
- 1994-10-11 HU HU9402933A patent/HUT70048A/hu unknown
- 1994-10-11 US US08/320,270 patent/US5502059A/en not_active Expired - Fee Related
- 1994-10-11 TW TW083109399A patent/TW300890B/zh active
- 1994-10-12 CN CN94117090A patent/CN1108651A/zh active Pending
- 1994-10-12 JP JP6246609A patent/JPH07278114A/ja not_active Withdrawn
- 1994-10-12 NZ NZ264661A patent/NZ264661A/en unknown
- 1994-10-12 ZA ZA947957A patent/ZA947957B/xx unknown
- 1994-10-12 AU AU75753/94A patent/AU685154B2/en not_active Ceased
- 1994-10-12 KR KR1019940026157A patent/KR950011413A/ko not_active Application Discontinuation
-
1995
- 1995-05-16 US US08/442,106 patent/US5523455A/en not_active Expired - Fee Related
- 1995-05-16 US US08/442,105 patent/US5585497A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU7575394A (en) | 1995-05-04 |
| NZ264661A (en) | 1996-08-27 |
| FR2711140A1 (fr) | 1995-04-21 |
| EP0647629B1 (de) | 1999-07-07 |
| FR2711140B1 (fr) | 1996-01-05 |
| US5585497A (en) | 1996-12-17 |
| ZA947957B (en) | 1995-05-22 |
| CN1108651A (zh) | 1995-09-20 |
| HU9402933D0 (en) | 1995-01-30 |
| RU2140912C1 (ru) | 1999-11-10 |
| NO943837D0 (no) | 1994-10-11 |
| US5502059A (en) | 1996-03-26 |
| CA2117821A1 (en) | 1995-04-13 |
| FI944770A (fi) | 1995-04-13 |
| HUT70048A (en) | 1995-09-28 |
| JPH07278114A (ja) | 1995-10-24 |
| RU94036749A (ru) | 1996-10-10 |
| NO943837L (no) | 1995-04-18 |
| KR950011413A (ko) | 1995-05-15 |
| TW300890B (de) | 1997-03-21 |
| NO304595B1 (no) | 1999-01-18 |
| AU685154B2 (en) | 1998-01-15 |
| DE69419377D1 (de) | 1999-08-12 |
| IL111239A0 (en) | 1994-12-29 |
| FI944770A0 (fi) | 1994-10-11 |
| US5523455A (en) | 1996-06-04 |
| EP0647629A1 (de) | 1995-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69419377D1 (de) | Neurotensin-aktive substituierte 1-Naphthylpyrazol-3-carboxamide, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
| SE8700499D0 (sv) | Novel pharmacologically active compounds | |
| NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
| ATE124401T1 (de) | Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel. | |
| IE862554L (en) | Pharmaceutical compositions | |
| ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
| NO921835L (no) | Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav | |
| DE3686483T2 (de) | Arzneimittel. | |
| ATE172969T1 (de) | Polyzyklische aromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und deren verwendungen | |
| SE8600658D0 (sv) | Novel composition of matter | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| FI923751A (fi) | Hexahydrobenso/f/kinolinoner | |
| DE69403110D1 (de) | Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen | |
| MX9203900A (es) | Composicion farmaceutica que comprende derivados de acido benzimidazolin-2-oxo-1-carboxilico. | |
| ATE97130T1 (de) | 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln. | |
| FI883455A0 (fi) | Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |